Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01838096

Enrollment

Registered

2013-04-23

Start date

2008-03-31

Completion date

2023-11-30

Last updated

2022-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Hip Disease

Brief summary

This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty (THA) in patients younger than 30 years.

Interventions

DEVICETHA using 4th generation CoC

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

15 Years to 30 Years

Healthy volunteers

Inclusion criteria

* younger than 30 years * advanced hip disease

Exclusion criteria

* older than 30 years

Design outcomes

Primary

Measure	Time frame	Description
survival rate of 4th generation ceramic-on-ceramic THA	5 years	survival rate of 4th generation ceramic-on-ceramic THA end point for best senario ; any reoperation end point for moderate senario ; loosening end point for worst senario ; osteolysis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026